![]() |
Volumn 30, Issue 12, 2011, Pages 2252-2258
|
Interview: The researcher-in-chief at the patient-centered outcomes research institute
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
BIOMEDICINE;
CANCER CHEMOTHERAPY;
COMPARATIVE EFFECTIVENESS;
COST EFFECTIVENESS ANALYSIS;
DATA BASE;
DIABETES MELLITUS;
FUNDING;
GENERAL PRACTITIONER;
GLYCEMIC CONTROL;
HEALTH CARE DELIVERY;
HEALTH CARE ORGANIZATION;
HEALTH CARE PERSONNEL;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HEALTH SURVEY;
HIGH RISK PATIENT;
HUMAN;
LEADERSHIP;
MEDICAL RECORD;
MEDICAL RESEARCH;
MEDICAL STAFF;
MEDICOLEGAL ASPECT;
METHODOLOGY;
MONEY;
NOTE;
OBSERVATIONAL METHOD;
OUTCOMES RESEARCH;
PATIENT CARE;
PEDIATRICIAN;
PERSONALIZED MEDICINE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SCIENTIST;
TEAMWORK;
UNITED STATES;
VETERAN;
|
EID: 84855665758
PISSN: 02782715
EISSN: 15445208
Source Type: Journal
DOI: 10.1377/hlthaff.2011.1233 Document Type: Note |
Times cited : (7)
|
References (0)
|